NCT01849302

Brief Summary

Over the last decades, changes in the diet and lifestyle have led to overall energy imbalance becoming commonplace and the emergence of an obesity epidemic with more than 1.6 billion adults being overweight. Consumption of foods that can affect appetite by increasing satiety could regulate the total energy intake and thus body weight. There is data suggesting that the macronutrient composition of the foods and especially protein content may have a potent role on satiety. However, it is difficult to pinpoint the optimum quantity needed to observe significant effects of protein on satiety. The research project is dedicated to identify which food components \[proteins, carbohydrates (CHO), fats\] and the optimized protein quantity needed to accelerate satiation, suppress appetite and extend satiety until hunger appears again. It is hypothesized that the consumption of protein-enriched meals will induce a reduction in hunger through the impact on gut hormones and peptides that are closely related to the short-term regulation of food intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2013

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 8, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

March 8, 2016

Status Verified

March 1, 2016

Enrollment Period

5 months

First QC Date

April 30, 2013

Last Update Submit

March 6, 2016

Conditions

Keywords

AppetiteSatiety hormonesDietary Protein

Outcome Measures

Primary Outcomes (1)

  • Changes from baseline in perceived appetite and satiety

    The appetite profile is assessed using validated Visual Analogue Scales (VAS) ratings (i.e hunger, fullness, desire to eat, prospective food consumption). The Questionnaires are performed electronically in personal laptops using the Adaptive Visual Analogue Scales (AVAS) software.

    Assessed every 30 min for 270 min after each of the seven beverages which are served at least one week apart (7 weeks)

Secondary Outcomes (4)

  • Ad libitum energy intake

    Energy intake is assessed 210 min after the 7 test beverages, which are served one week apart.

  • Changes from baseline in the postprandial concentration of satiety hormones

    Assessed at 6 points in time over the morning of each of the 7 test days, which are separated by 1 week (7 weeks)

  • Hedonic ratings and palatability of the test beverages and meals

    Assessed immediately after consumption of the 7 test beverages and pasta meal (7 weeks)

  • Changes from baseline in the postprandial concentration of glucose

    Assessed at 7 points in time over the morning of each of the 7 test days, which are separated by 1 week (7 weeks)

Study Arms (7)

High protein/ High fat beverage

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 40 E% Protein, 42 E% fat Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

High protein/ Normal CHO beverage

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 40 E% Protein, 47 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

Low protein/ High fat beverage

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 9 E% Protein, 63 E% fat Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

Low protein/ High CHO beverage

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 9 E% Protein, 71 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

Normal protein/ Normal CHO beverage 1

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 24 E% Protein, 50 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

Normal protein/Normal CHO beverage 2

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 24 E% Protein, 50 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

Normal protein/Normal CHO beverage 3

EXPERIMENTAL

Beverage based on milk protein: 1.8 MJ, 24 E% Protein, 50 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake

Dietary Supplement: Beverages varying in macronutrient content on appetite

Interventions

In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients. The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.

High protein/ High fat beverageHigh protein/ Normal CHO beverageLow protein/ High CHO beverageLow protein/ High fat beverageNormal protein/ Normal CHO beverage 1Normal protein/Normal CHO beverage 2Normal protein/Normal CHO beverage 3

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy males and females
  • Age range 18-50 years
  • Normal weight and overweight people as classified by BMI:22-27.9 kg/m2 (inclusive).
  • Understanding English well and feeling comfortable speaking it

You may not qualify if:

  • Dietary protein consumption \>25% energy from protein
  • Had surgery in the previous 12 months
  • Have suffered a myocardial infarction or stroke at any time
  • Suffer from any blood-clotting disorder or prescription of any medication affecting blood clotting
  • Suffer from any metabolic disorders (e.g. diabetes, metabolic syndrome or hypertension)
  • Any requirement to take long-term medication, especially those active on the gastro-intestinal tract or for cardio-vascular disease
  • Any dietary restrictions or recently/currently on a weight reducing diet
  • Irregular eating patterns or not regularly consuming breakfast
  • Food allergies (e.g. milk protein allergies) or intolerances (e.g. lactose)
  • Use of medication which affects food intake or behaviour (e.g. anti-depressants)
  • Use of medication likely to affect taste, smell or appetite
  • Eating restraint based on the three Factor Eating Questionnaire
  • Use of any protein supplements
  • A history of alcohol or drug misuse (the average daily number of units of alcohol considered as acceptable is 2-3 units women; 3-4 units men
  • Smoking
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Applied Nutrition and Food Chemistry

Lund, Skåne County, 221 00, Sweden

Location

Related Publications (1)

  • Dougkas A, Ostman E. Protein-Enriched Liquid Preloads Varying in Macronutrient Content Modulate Appetite and Appetite-Regulating Hormones in Healthy Adults. J Nutr. 2016 Mar;146(3):637-45. doi: 10.3945/jn.115.217224. Epub 2016 Jan 20.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Anestis Dougkas, PhD

    Lund University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral Research Fellow

Study Record Dates

First Submitted

April 30, 2013

First Posted

May 8, 2013

Study Start

March 1, 2013

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

March 8, 2016

Record last verified: 2016-03

Locations